We are pleased to announce the presentation of our latest research poster: "Development of a Scoring System to Classify HER2 Protein Expression in Circulating Tumor Cells through Immunofluorescence Following Isolation Using Parsortix® Instruments

President, CEO

New Collaborative Research Update from BioView and ANGLE. We are pleased to announce the presentation of our latest research poster: “Development of a Scoring System to Classify HER2 Protein Expression in Circulating Tumor Cells through Immunofluorescence Following Isolation Using Parsortix® Instruments.” The study concludes that changes in the HER2 status over time potentially identified in historical patient samples highlight the potential of liquid biopsy and concomitant evaluation of HER2 protein expression and gene amplification in CTCs, for minimally-invasive disease monitoring of patients undergoing treatment for metastatic breast cancer, to enable more accurate stratification of patients that may benefit from HER2 targeted therapy.